© The Author 2006. Published by Oxford University Press.
CORRESPONDENCE |
Re: Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas
Affiliations of authors: Department of Tumor Biology (PD, AV-S, MT, M-CE), Department of Clinical Hematology (DC, DD), Department of Ophthalmology (PA, LL-LR), Department of Radiation Oncology (R. Dolcetti), Institut Curie, Paris, France; Unité de Biologie des Interactions cellulaires, URA CNRS 2582, Institut Pasteur, Paris, France (AS); Department of Oncology (AJMF), Department of Pathology (MP), San Raffaele H Scientific Institute, Milan, Italy; Immunovirology and Biotherapy Unit, Department of Pre-clinical and Epidemiological Research, Centro di Riferimento Oncologico IRCCS National Cancer Institute, Aviano, Italy (FS, R. Dendale); Inserm/Institut Curie U 509, Paris, France (M-HS)
Correspondence to: Didier Decaudin, MD, PhD, Service d'Hématologie Clinique, Institut Curie, 26 rue d'Ulm, 75.248 Paris cedex 05, France (e-mail: didier.decaudin@curie.net).
| The first 10% of the full text of this article appears below. |
Ferreri et al. (1) recently reported that patients with ocular adnexal lymphoma had a high prevalence of Chlamydia psittaci infection in both tumor tissues and peripheral blood mononuclear cells. More recently, one study reported a similar prevalence of the infection in a Korean patient series (2), whereas three other studies did not
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. J. M. Ferreri, R. Dolcetti, M.-Q. Du, C. Doglioni, A. Giordano Resti, L. S. Politi, C. De Conciliis, J. Radford, F. Bertoni, E. Zucca, et al. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy Ann. Onc., May 1, 2008; 19(5): 835 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M L Cohen, J. Sweetenham, and A. D Singh Ocular adnexal lymphoma. What is the evidence for an infectious aetiology? Br J Ophthalmol, April 1, 2008; 92(4): 446 - 448. [Full Text] [PDF] |
||||

